PMID- 3606632 OWN - NLM STAT- MEDLINE DCOM- 19870803 LR - 20190623 IS - 0006-2952 (Print) IS - 0006-2952 (Linking) VI - 36 IP - 13 DP - 1987 Jul 1 TI - Inter-organ metabolism and transport of a cysteine-S-conjugate of xenobiotics in normal and mutant analbuminemic rats. PG - 2145-50 AB - Biosynthesis of N-acetylcysteine S-conjugates of toxic electrophiles, mercapturic acids, occurs via inter-organ metabolism and transport in which liver, small intestine and kidney play an important role. Since a mercapturic acid is a hydrophobic organic anion and strongly binds to plasma albumin in vitro, the ligand-albumin interaction may affect the metabolic fate of this final metabolite in vivo. To investigate the role of the circulating albumin in detoxication and elimination of a toxic electrophile, urinary occurrence of the final metabolite was determined in normal and mutant Nagase analbuminemic rats (NAR) after administration of S-benzylcysteine, a model compound of cysteine conjugates. S-Benzylcysteine intravenously administered was excreted rapidly into urine as its N-acetyl derivative in both animal groups. However, the urinary recovery of this mercapturic acid was significantly lower in NAR than in normal animals. The lower urinary recovery in NAR was due to a rapid and random distribution of the unbound metabolite in the circulation to extrarenal tissues. In contrast, no significant difference in the urinary recovery of the final metabolite was observed between the two animal groups if S-benzylcysteine was given orally. Kinetic analysis revealed that the major part of the orally administered S-benzylcysteine was transferred to the liver and acetylated predominantly in this organ in both animal groups; the mercapturic acid which was synthesized in the liver can be transferred to the kidney and excreted into urine even in the absence of the circulating albumin. These results indicate that albumin is important for a final elimination of a mercapturic acid when animals were extraorally challenged with a large dose of toxic electrophiles by which the rate of biosynthesis and the plasma level of the amphipathic metabolites were increased. FAU - Inoue, M AU - Inoue M FAU - Okajima, K AU - Okajima K FAU - Nagase, S AU - Nagase S FAU - Morino, Y AU - Morino Y LA - eng PT - Journal Article PL - England TA - Biochem Pharmacol JT - Biochemical pharmacology JID - 0101032 RN - 0 (Blood Proteins) RN - 0 (Serum Albumin) RN - 9VRE13M548 (S-benzylcysteine) RN - EC 2.3.1.5 (Arylamine N-Acetyltransferase) RN - K848JZ4886 (Cysteine) RN - WYQ7N0BPYC (Acetylcysteine) SB - IM MH - Acetylation MH - Acetylcysteine/*metabolism MH - Animals MH - Arylamine N-Acetyltransferase/metabolism MH - Blood Proteins/metabolism MH - Cysteine/*analogs & derivatives/urine MH - Intestine, Small/enzymology MH - Kidney/enzymology MH - Kinetics MH - Liver/enzymology MH - Male MH - Rats MH - Rats, Inbred Strains MH - Serum Albumin/*deficiency/physiology EDAT- 1987/07/01 00:00 MHDA- 1987/07/01 00:01 CRDT- 1987/07/01 00:00 PHST- 1987/07/01 00:00 [pubmed] PHST- 1987/07/01 00:01 [medline] PHST- 1987/07/01 00:00 [entrez] AID - 0006-2952(87)90143-2 [pii] AID - 10.1016/0006-2952(87)90143-2 [doi] PST - ppublish SO - Biochem Pharmacol. 1987 Jul 1;36(13):2145-50. doi: 10.1016/0006-2952(87)90143-2.